Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `jetpack` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/grassnews/public_html/wp-includes/functions.php on line 5905
Village Farms International Reports Third Quarter 2019 Financial Results – Canadian Cannabis JV, Pure Sunfarms, Achieves Fourth Consecutive Quarter of Positive EBITDA, All-In Cost of Production of C$0.63 per Gram, Gross Margin of 69% and EBITDA Margin of 56% – GrassNews
Connect with us

Cannabis

Village Farms International Reports Third Quarter 2019 Financial Results – Canadian Cannabis JV, Pure Sunfarms, Achieves Fourth Consecutive Quarter of Positive EBITDA, All-In Cost of Production of C$0.63 per Gram, Gross Margin of 69% and EBITDA Margin of 56%

Published

4 years ago

on

Photo source: theemeraldmagazine.com

 

Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (NASDAQ: VFF) today announced its financial results for the third quarter and nine-month period ended September 30, 2019.  All figures are in U.S. dollars unless otherwise indicated.

Village Farms’ Financial and Corporate Highlights for the Third Quarter Ended September 30, 2019
(All comparable figures are for the third quarter ended September 30, 2018)

  • Produce sales were US$38.3 million compared with US$39.7 million;
  • Net loss before tax of (US$6.5 million) and included the loss from Pure Sunfarms Corp. (“Pure Sunfarms”) of (US$0.9 million) (Village Farms’ share based on its 50% ownership).  This compares with a net loss before tax of (US$2.7 million);
  • Loss per share was (US$0.10) compared with loss per share of (US$0.04);
  • EBITDA loss was (US$2.4 million), including the positive contribution from Pure Sunfarms of US$5.0 million (C$6.6 million) (Village Farms’ 50% share).  This compares with an EBITDA loss of (US$2.0 million); and
  • Subsequent to quarter end, completed a bought deal offering of 3,059,000 common shares at a price of C$9.40 per share for aggregate gross proceeds to the Company of C$28,754,600.

Third Quarter Financial Results for Village Farms’ Canadian Cannabis Joint Venture, Pure Sunfarms
(There were are no comparable results for the third quarter ended September 30, 2018 as no production existed.)

  • Net sales (before Village Farms’ 50% share), which consisted entirely of dried cannabis sold predominantly to other licensed producers, were C$24.0 million (US$18.1 million).  Late in the third quarter, Pure Sunfarms began shipping branded packaged product to the Ontario Cannabis Store (“OCS”);
  • Sales for the third quarter did not include C$7.2 million that was invoiced to Emerald Health Therapeutics (see “Update on Pure Sunfarms’ Supply Agreement with Emerald Health Therapeutics” below);
  • Cost of goods sold (“all in cost”) per gram was C$0.63 (US$0.48) per gram;
  • Gross margin was 69%;
  • Selling, general and administrative expenses (before Village Farms’ 50% share) of C$3.7 million (US$2.8 million) or 12% of revenue;
  • Net loss (before Village Farms’ 50% share) of (C$2.4 million) ((US$1.8 million)) which included the non-cash impact of a net charge of (C$12.6 million) due to a change in value of the biological asset; and,
  • EBITDA (before Village Farms’ 50% share) was C$13.3 million (US$10.1 million), marking Pure Sunfarms’ fourth consecutive quarter of positive EBITDA and resulting in an EBITDA margin of 56%.

Recent Highlights for Village Farms’ Canadian Cannabis Joint Venture, Pure Sunfarms

  • Pure Sunfarms was the top performing brand of dried flower by both kilograms sold and dollar sales with the OCS in October 2019, achieving 16% market share (by kilograms sold).  Pure Sunfarms’ dried flower products outsold the second ranked dried flower brand’s products two to one (by kilograms sold).  In addition:
    • Pure Sunfarms’ Afghan Kush was the top selling dried flower product with the OCS in October;
    • Three of the seven top selling dried flower products with the OCS in October were Pure Sunfarms products

      Pure Sunfarms shipped its first order of branded dried cannabis products to the OCS in late September (followed by multiple reorders) following receipt from Health Canada on September 6, 2019 of the amendment to its license permitting it to sell and distribute packaged, branded dried cannabis products directly to provincial/territorial wholesalers and authorized private retailers in Canada;
  • In B.C., Pure Sunfarms’ sold out its first order to the BC Liquor Distribution Branch (“BCLDB”) (which has since re-ordered) in under three weeks to rank among the top ten brands by sales for all product categories in October.  Pure Sunfarms began selling branded, packaged dried cannabis products to the BCLDB in October following entry into a supply agreement in September;
  • Completed installation of extraction equipment (with processing capacity of 35,000 kilograms of biomass annually) in its new 65,000 square foot state-of-the-art processing center within the Delta 3 greenhouse facility in preparation for Cannabis 2.0. The processing centre has been designed for full GMP compliance and certification to allow for future exportation, and is expected to be operational as soon as possible, subject to Health Canada licensing and in-house calibration and testing;
  • Achieved full run-rate annual production of 75,000 kilograms of dried cannabis at its 1.1 million square foot Delta 3 greenhouse facility; and
  • Commenced conversion of the interior of its second 1.1 million square foot greenhouse operation, the Delta 2 greenhouse facility, for cannabis production, which is conservatively expected to double Pure Sunfarms’ annual output at full production to more than 150,000 kilograms.  Conversion of the Delta 2 greenhouse facility, which has been designed for full GMP compliance and certification to all for future exportation, remains on schedule, with cannabis production expected to commence during the second quarter of 2020 and the facility is expected to be operating at full run rate production by the end of 2020.  Pure Sunfarms has submitted to Health Canada its application for the initial Cultivation License for the Delta 2 greenhouse facility.

Recent Highlights for Village Farms’ U.S. Hemp/CBD Program

The Company’s joint ventures for outdoor hemp production and processing in the U.S. recently completed harvesting of approximately 625 acres of the approximately 870 acres of hemp planted in 2019, achieving an average yield of approximately 1,600 pounds per acre harvested, well in excess of its projections. The Company expects to commence sales of hemp biomass as early as the fourth quarter of 2019.

“We are pleased to report another quarter in which Pure Sunfarms continued to set the standard for performance as a best-in-class cannabis operation, which again drove strong financial performance,” said Michael DeGiglio, Chief Executive Officer, Village Farms.  “Pure Sunfarms’ achieved its fourth consecutive quarter of positive EBITDA, with an industry leading all-in cost of production of C$0.63, gross margin of 69% and EBITDA margin of 56%.  In the 12 months since adult-use cannabis was legalized in Canada in October 2018, Pure Sunfarms has already generated C$47 million in EBITDA, an especially impressive number given that its operations were ramping up throughout most of that period.”

“Pure Sunfarms is now proving itself as a leading cannabis brand, ranking as the number one selling dried flower brand by a wide margin with the Ontario Cannabis Store in October, and having the overall top selling dried flower product, as well as three of the seven top-selling dried flower product. We look forward to Pure Sunfarms building on this tremendous initial success as it launches its pre-rolled dried products, adds provincial supply agreements, starts its extraction operations online for the roll out of oils and other new product forms under Cannabis 2.0 in the first half of next year, and more than doubles its output, further supporting its low production costs.”

“Pure Sunfarms continues to execute very well on what is under its control.  Even as one of the largest Canadian adult-use cannabis suppliers by dollars sold, third quarter sales were constrained by the limited physical retail store infrastructure in Canada, as well as the C$7.2 million that could not be recognized. We built Pure Sunfarms, however, for profitability out of the gate, even in a commoditized environment, and it is one of the few and most profitable Canadian cannabis companies.  With industry-leading cost production and a brand and products that are clearly resonating with consumers, Pure Sunfarms remains well positioned to continue to be a dominant supplier as the Canadian adult-use cannabis market continues to develop and expand.”

“In our U.S. outdoor hemp program, we recently completed harvest of our 2019 crop, highlighted by yields that were well above our projections.  We remain on track to begin generating profitable hemp sales as early as the fourth quarter of this year.  Importantly, our first growing season has provided significant learnings that will be invaluable going forward.  In our greenhouse hemp program, we continue to work with Texas Department of Agriculture on the implementation of its hemp regulatory framework subject to the recently published US Department of Agriculture rules and are optimistic that licensing could commence in the first quarter of 2020.  As we did in Canada with Pure Sunfarms, we are building a rock-solid foundation of exceptional growing operations from which to aggressively pursue our objective to launch our own white-labelled and branded CBD products in 2020.”

“In our produce business, we continue to make steady progress in the transition of the production displaced for cannabis and hemp production to third-party growing partners, recently adding approximately 120 acres with partners in Mexico and Canada to bring the total to nearly 300 acres.  During this period of transition, we will continue to experience some impact on our financial results, more so in some quarters than others, which in the third quarter contributed to a net loss for the produce business of US$5.1 million.”

Update on Pure Sunfarms’ Supply Agreement with Emerald Health Therapeutics

Pursuant to the terms of a Supply Agreement that Pure Sunfarms has with Emerald Health, Emerald has an obligation to purchase 40% of Pure Sunfarms cannabis production at a fixed price, subject to the terms and conditions of the Supply Agreement. To the extent that Emerald does not fulfill its purchase obligation, Pure Sunfarms is able to sell that excess production to other parties in the open market. The Supply Agreement stipulates that Emerald is required to pay Pure Sunfarms the difference between the fixed price and the selling price realized from other parties.  During the quarter ended September 30, 2019, Emerald did not fulfill its purchase obligation and Pure Sunfarms sold the product on the open market to arm’s length parties at prices lower than the fixed price in the Supply Agreement. As a result, under the terms of the Supply Agreement, Pure Sunfarms billed Emerald for the difference which amounted to approximately C$7.2 million. On October 15, 2019, Emerald issued a press release that indicated they do not agree that they have any liability with respect to these amounts.

Under IFRS 15 – Revenue from contracts with customers (paragraph 9 (e)), a customer needs to have an intent and ability to pay in order for a company to recognize revenue. Given that Emerald has issued a press release indicating that they do not agree that they have a liability with respect to these amounts, Pure Sunfarms has determined that all of the criteria under IFRS 15 to recognize this revenue were not met as Emerald has demonstrated that they do not have an intent to pay, and as a result has not recorded the revenue related to these amounts.

We understand that Emerald is in the process of investigating its liability to Pure Sunfarms.  If Emerald does not agree to the liability, Pure Sunfarms has reserved the right to take such actions as it considers necessary and appropriate to recover its losses from Emerald for non-payment of amounts owing under the Supply Agreement.   If Emerald were to agree to the liability in the future, such liability would be recognized in the revenue and profits of Pure Sunfarms, at such time in accordance with generally accepted accounting principles.

Summary Statutory Results
(in thousands of U.S. Dollars unless otherwise indicated)

For the three months
ended September 30,

For the Nine months
ended September 30,

2019

2018

2019

2018

Produce sales

$38,293

$39,684

$111,512

$111,213

Cost of sales

(38,866)

(36,862)

(114,711)

(103,915)

Selling, general and administrative expenses

(3,739)

(3,442)

(11,682)

(10,486)

Stock compensation expense

(868)

(190)

(3,190)

(447)

Change in biological asset (1)

(627)

(1,189)

(97)

(992)

Loss from operations

(5,807)

(1,999)

(18,168)

(4,627)

Interest expense, net

(393)

(618)

(1,503)

(1,906)

Foreign exchange gain (loss)

(183)

(73)

338

(87)

Other income, net

69

17

219

61

Share of income (loss) from joint ventures

(171)

(28)

17,939

(369)

Gain on disposal of assets

(8)

–

13,558

–

(Provision for) recovery of income taxes

1,421

712

81

1,513

Net income (loss)

(5,072)

(1,989)

12,464

(5,415)

Consolidated EBITDA (2)

2,383

897

8,256

1,394

Earnings (loss) per share – basic

($0.10)

($0.04)

$0.26

($0.12)

Earnings (loss) per share – diluted

($0.10)

($0.04)

$0.25

($0.12)

Summary Results Including Joint Ventures, on a Proportionate Basis

The following results reflect the Company’s proportionate share of the Pure Sunfarms joint venture operations, as this is the basis on which management bases its operating decisions and performance.  For a reconciliation to the results in accordance with International Financial Reporting Standards (“IFRS”) refer to the “Reconciliation of IFRS to Proportionate Results” as presented below and in Management’s Discussion & Analysis (“MD&A”).

(in thousands of U.S. Dollars unless otherwise indicated)

For the three months
ended September 30,

For the six months
ended September 30,

2019(3)

2018(3)

2019(3)

2018(3)

Consolidated sales

$47,335

$39,779

$138,076

$111,308

Cost of sales

(41,711)

(36,934)

(121,443)

($103,987)

Selling, general and administrative expenses

(5,376)

(3,756)

(14,860)

(11,302)

Change in biological asset (1)

(4,057)

(921)

6,873

(564)

Gain on disposal of assets

(8)

–

13,558

–

Net income (loss)

(5,072)

(1,989)

12,464

(5,415)

EBITDA(2)

$2,377

$897

$8,256

$1,394

Earning (loss) per share – basic

($0.10)

($0.04)

$0.26

($0.12)

Earning (loss) per share – diluted

($0.10)

($0.04)

$0.25

($0.12)

Notes:

(1)

Biological asset consists of the Company’s produce on the vines and Pure Sunfarms’ crop at the period end.  Details of the changes are described in note 5 of the Company’s interim condensed consolidated financial statements for the nine months ended September 30, 2019.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS.  Therefore, EBITDA may not be comparable to similar measures presented by other issuers.  See “Non-IFRS Measures”.  Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated EBITDA includes the Company’s 50% interest in Pure Sunfarms, 65% interest in VFH and 60% (effective 63.25% with VFH interest) interest in AVGGH.

(3)

The consolidated financial results above reflect the proportionate share of the Company’s share of revenues and expenses from its joint venture operations, as this is the basis which management bases its operating decisions and performance evaluation.  IFRS does not allow for the inclusion of the joint venture on a proportionate basis.  These results include additional non-IFRS measures such as EBITDA.

The results are not generally accepted measures of financial performance under IFRS.  The Company’s method of calculating these financial performance measures may differ from other companies and accordingly, they may not be comparable to measures used by other companies.  Refer to the MD&A for a reconciliation of these non-IFRS measures and proportionate results.

Financial Highlights
(All amounts in U.S. Dollars unless otherwise indicated.)

Cannabis

For the three months ended September 30, 2019.  There are no comparable results for the three months ended September 30, 2018 as no production existed.

The Company’s 50% share of net sales of Pure Sunfarms for the three months ended September 30, 2019 was $9,042.  Total Pure Sunfarms sales consisted of close to approximately 12,000 kilograms of flower and trim sold at an average selling price of over $1.50 per gram (C$2.00 per gram) during the three months ended September 30, 2019. Sales for the three months ended September 30, 2019 were predominantly to other licensed producers and do not include $5.4 million (C$7.2 million) invoiced to Emerald that was not able to be recognized as per the discussion above.

The Company’s 50% share of cost of sales of Pure Sunfarms for the three months ended September 30, 2019 was $2,845.

The Company’s 50% share of selling, general and administrative expenses of Pure Sunfarms for the three months ended September 30, 2019 was $1,415.

The Company’s 50% share of net loss for the three months ended September 30, 2019 was ($918) compared to ($28) for the three months ended September 30, 2018.  The net loss for the three months ended September 30, 2019 is due to a change in the biological asset of ($4.8 million).

The Company’s 50% share of EDITDA for the three months ended September 30, 2019 was $5,033 compared to ($12) for the three months ended September 30, 2018.

For the nine months ended September 30, 2019.  There are no comparable results for the nine months ended September 30, 2018 as no production existed. 

The Company’s 50% share of net sales of Pure Sunfarms for the nine months ended September 30, 2019 was $26,564.  Total Pure Sunfarms sales consisted of close to 24,600 kilograms of flower and trim during the nine months ended September 30, 2019, at an average sales price of approximately $2.15 per gram (C$2.85 per gram).

The Company’s 50% share of cost of sales of Pure Sunfarms for the nine months ended September 30, 2019 was $6,732 (based on total grams sold of close to 24,600 kilograms), or approximately $0.55 per gram (C$0.73 per gram).

The Company’s 50% share of selling, general and administrative expenses of Pure Sunfarms for the nine months ended September 30, 2019 was $2,808 and primarily consisted of personnel costs and Health Canada fees.

Income from operations for the Company’s 50% share of Pure Sunfarms was $22,658 for the nine months ended September 30, 2019.

The Company’s 50% share of net income for the nine months ended September 30, 2019 was $17,342 versus a loss of ($369) for the nine months ended September 30, 2018.

The Company’s 50% share of EBITDA for the nine months ended September 30, 2019 was $17,704 versus ($363) for the same period in 2018.

Produce

For the three months ended September 30, 2019 compared to the three months ended September 30, 2018.

Sales for the three months ended September 30, 2019 decreased by ($1,391), or (4%), to $38,293 from $39,684 for the three months ended September 30, 2018.  The decrease in sales is primarily due to a decrease in the Company’s product volume, as well as a decrease in supply partner revenue.

Cost of sales for the three months ended September 30, 2019 increased by $2,004, or 5%, to $38,866 from $36,862 for the three months ended September 30, 2018, primarily due to an increase in cost per pound from the Texas facilities, which is due to production issues that caused decreases in production.  The decrease in production for the crop causes an increase in cost per pound as most costs are fixed and, as production decreases, cost per pound increases.

For the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

Sales for the nine months ended September 30, 2019 increased $299, or less than 1%, to $111,512 compared to $111,213 for the nine months ended September 30, 2018.   The increase in net sales is due to an increase in supply partner revenues of 12% over the comparable period in 2018 partially offset by a (14%) decrease in the Company’s production volume.  The decrease in the Company’s production volume is primarily due to a clean-out in one of Company’s facilities (which did not occur in the last three years) and ongoing virus pressure at the Company’s Texas facilities.

Cost of sales for the nine months ended September 30, 2019 increased $10,796, or 10%, to $114,711 from $103,915 for the nine months ended September 30, 2018, due to an increase in supply partner purchases of 12% and an increase in the cost per pound of the Company’s own grown product in Texas due to decreased pounds and higher labor costs, due to the higher utilization of hourly rate contract laborers versus Village Farms’ employees for the 2018/2019 crop as compared to the prior crop.

Consolidated EBITDA

EBITDA for the three months ended September 30, 2019 increased by $4,339 to $5,236 from $897 for the three months ended September 30, 2018. The increase is primarily as a result of an increase in the Company’s share of EDITDA from Pure Sunfarms of $7,886 partially offset by an increase in the loss from operations for the Company’s produce business.

EBITDA for the nine months ended September 30, 2019 increased $9,713 to $11,109 from $1,394 for the nine months ended September 30, 2018, primarily as a result of an increase in the Company’s share of income from Pure Sunfarms (Pure Sunfarms EBITDA – $20,558) partially offset by an increase in the loss from the Company’s produce business.

Non-IFRS Measures

References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales.  EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:

(in thousands of U.S. dollars)

For the three months
ended September 30, 

For the nine months
ended September 30,

2019

2018

2019

2018

Net income (loss)  

($5,072)

($1,989)

$12,464

($5,415)

Add:

Amortization

1,818

1,748

5,587

5,271

Foreign currency exchange loss (gain) 

183

73

(338)

87

Interest expense, net

393

618

1,503

1,906

Income taxes (recovery)

(1,421)

(712)

(81)

(1,513)

Stock based compensation

868

190

3,190

447

Change in biological asset

627

1,189

97

992

Change in biological asset for JV’s

3,430

(267)

(6,970)

(428)

Interest expense for JV’s

249

–

446

–

Amortization for JV’s

244

37

668

37

Foreign currency exchange loss (gain) for JV’s

(7)

10

(14)

10

Income taxes (recovery) from JV’s

1,057

5,262

–

Gain on disposal of assets

8

–

(13,558)

–

EBITDA

$2,377

$897

$8,256

$1,394

EBITDA for JV’s (See table below)

$4,806

($248)

$17,331

($750)

EBITDA excluding JVs(produce)

($2,429)

$1,145

($9,076)

$2,144

Breakout of JV’s EBITDA

(in thousands of U.S. dollars)

For the three months
ended September 30, 

For the nine months
ended September 30,

2019

2018

2019

2018

Pure Sunfarms EBITDA

$5,033

($248)

$17,704

($750)

VFH EBITDA

(204)

–

(330)

–

AVGGH EBITDA

(23)

–

(43)

–

Total JV’s EBITDA

$4,806

($248)

$17,331

($750)

Reconciliation of IFRS to Proportionate Results

The following tables are a reconciliation of the IFRS results to the proportionate results (which include the Company’s proportionate share of the Pure Sunfarms operations):

For the three months ended September 30, 2019

Produce

PSF(4)

Hemp(4)

Total

Sales

$38,293

$9,042

$-

$47,335

Cost of sales

(38,866)

(2,845)

–

(41,711)

Selling, general and administrative expenses

(3,739)

(1,415)

(222)

(5,376)

Stock compensation expense

(868)

–

–

(868)

Change in biological asset (5)

(627)

(4,765)

1,336

(4,056)

Other income (expense) net

(507)

(140)

(99)

(746)

(Provision for) recovery of income taxes

1,421

(794)

(268)

359

Net income (loss)

($4,901)

($918)

$747

($5,072)

EBITDA (6)

($2,422)

$5,033

($227)

$2,383

Earnings (loss) per share – basic

($0.10)

($0.02)

$0.02

($0.10)

Earnings (loss) per share – diluted

($0.10)

($0.01)

$0.01

($0.10)

For the three months ended September 30, 2018

Produce

PSF(4)

Hemp(4)

Total

Sales

$39,684

$95

–

$39,779

Cost of sales

(36,862)

(72)

–

(36,934)

Selling, general and administrative expenses

(3,442)

(314)

–

(3,756)

Stock compensation expense

(190)

–

–

(190)

Change in biological asset (5)

(1,189)

268

–

(921)

Other income (expense) net

(674)

(5)

–

(679)

Recovery of income taxes

712

–

–

712

Net income (loss)

($1,961)

($28)

–

($1,989)

EBITDA (6)

$1,145

($248)

–

$897

Earnings (loss) per share – basic

($0.03)

($0.01)

–

($0.04)

Earnings (loss) per share – diluted

($0.03)

($0.01)

–

($0.04)

For the nine months ended September 30, 2019

Produce

PSF(4)

Hemp(4)

Total

Sales

$111,512

$26,568

–

$138,076

Cost of sales

(114,711)

(6,732)

–

(121,443)

Selling, general and administrative expenses

(11,682)

(2,808)

(370)

(14,860)

Stock compensation expense

(3,190)

–

–

(3,190)

Change in biological asset (5)

(97)

5,634

1,336

6,873

Gain on disposal of assets

13,558

–

–

13,558

Other income (expense) net

(946)

(273)

(150)

(1,369)

(Provision for) recovery of for income taxes

81

(5,043)

(219)

(5,181)

Net income (loss)

($5,475)

$17,342

$597

$12,464

EBITDA (6)

($9,076)

$17,704

($373)

$8,256

Earnings (loss) per share – basic

($0.11)

$0.36

$0.01

$0.26

Earnings (loss) per share – diluted

($0.11)

$0.34

$0.01

$0.25

For the nine months ended September 30, 2018

Produce

PSF(4)

Hemp(4)

Total

Sales

$111,213

$95

$-

$111,308

Cost of sales

(103,915)

(72)

–

($103,987)

Selling, general and administrative expenses

(10,486)

(816)

–

(11,302)

Stock compensation expense

(447)

–

(447)

Change in biological asset (5)

(992)

428

–

(564)

(Gain) loss on sale of assets

–

–

–

–

Other income (expense) net

(1,932)

(5)

–

(1,937)

Recovery of income taxes

1,513

–

–

1,513

Net income (loss)

($5,046)

($369)

$-

($5,415)

EBITDA (6)

$2,149

($750)

$-

$1,394

Earnings (loss) per share – basic

($0.11)

($0.01)

$-

($0.12)

Earnings (loss) per share – diluted

($0.11)

($0.01)

$-

($0.12)

Notes:

(4)

The adjusted consolidated financial results have been adjusted to include the Company’s share of revenues and expenses from its Pure Sunfarms and Hemp joint ventures on a proportionate accounting basis, on which management bases its operating decisions and performance evaluation.  IFRS does not allow for the inclusion of the Joint Venture on a proportionate basis.  These results include additional non-IFRS measures such as EBITDA.

The adjusted results are not generally accepted measures of financial performance under IFRS.  The Company’s method of calculating these financial performance measures may differ from other companies and accordingly, they may not be comparable to measures used by other companies.  Refer to the MD&A for a reconciliation of these non-IFRS measures and adjusted results.

(5)

Biological asset consists of the Company’s produce on the vines and Pure Sunfarms’ crop at the period end.  Details of the changes are described in note 5 of the Company’s interim condensed consolidated financial statements for the nine months ended September 30, 2019.

(6)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS.  Therefore, EBITDA may not be comparable to similar measures presented by other issuers.  See “Non-IFRS Measures”.  Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated EBITDA includes the Company’s 50% interest Pure Sunfarms, 65% interest in VFH and 60% (effective 63.25% with VFH interest) interest in AVGGH.

Conference Call

Village Farms’ management team will host a conference call Friday, November 15, 2019 at 8:30 a.m. ET to discuss its third quarter 2019 financial results.  Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at: https://bit.ly/2Wm7dxj.

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 4987345 followed by the pound key. The telephone replay will be available until Friday, November 22, 2019 at midnight (ET).  The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network

Published

2 days ago

on

September 22, 2023

By

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) — FMW Media’s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street’s televised platforms on Newsmax and the FOX Business Network.

New to The Street airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM PT, featuring the following five (5) Corporate interviews:

1). American Made Products – American Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) interview with Andy Ross, Chairman/CEO.

2). E-commerce/ Digital Marketing – Society Pass Incorporated’s (NASDAQ: SOPA) ($SOPA) interview with Rokas Sidlauskas, Chief Marketing Officer.

3). Health Sciences – PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) interview with Stephen Van Deventer, Chairman/CEO.

4). Artist – Hope Tain Oil Painting’s interview with Hope Tain, Artist/Owner.

5). “Sekur Privacy & Sekur Security Segment – The Weekly Hack” interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®).

America Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) Chairman/CEO Andy Ross is with New to The Street’s TV Host Jane King. From the Nasdaq MarketSite studio, Andy talks about AREB, a NASDAQ publicly traded company that makes “American Made” products. Recognized as “America’s Patriotic Brand,” the Company has several product lines, including safes. A recent FBI raid on the home of a suspected participant on January 6, 2021, at the US Capitol Building revealed a disturbing issue. A competitor’s safe, Liberty Safe, was in the home, and the FBI contacted that manufacturer about the make and model and then Liberty handed over data to open the safe without proper legal premise. Andy explains to viewers that the Company would request appropriate legal service if the FBI contacted American Rebel regarding its Champion safe. Andy informs viewers that American Rebel believes in the United States’ Constitution and those rights inherent to Americans. Privacy is essential to every American, and if the FBI served the Company, Management would fight the legal subpoena under constitutional grounds. American Rebel would never hand over proprietary safe codes.. Demand is up for the Champion’s safes because of this FBI incident. American Rebel’s Champion Safes are affordable and reliable. Another soon-to-launch American Rebel product, “American Rebel Beer,” is coming to market. The US Beer market generates around $44B yearly, and American Rebel Beer is looking forward to breaking into the US Beer market. The roll-out of its lager and light beers will be regional, with the expectation of becoming national in 2024. It is working on other beer flavors, with roll-outs expected in the months ahead. During the Show, Andy announces his new Music CD, “I Stand for You,” which can be heard on airwaves or downloaded digitally. The American Rebel Beer jingle will air soon. Viewers can learn more about the Company’s mission and products through its strong social media presence, websites, and websites like www.americanrebel.com and www.andyross.com. The on-screen QR code is available during the show; download or visit America Rebel, Inc. – http://www.americanrebel.com/.

From the Nasdaq MarketSite studio, Rokas Sidlauskas, Chief Marketing Officer of Society Pass Incorporated (NASDAQ: SOPA) ($SOPA) (“Society Pass”) talks with New to The Street’s TV Host Jane King about SOPA. With a focus on acquisitions and growing its next-generation digital e-commerce platform, SOPA continues to onboard businesses and individuals throughout Southeast Asia. Rokas explains that with about 650 million people, SE Asia is a strong growing market, and SOPA has positioned itself to take advantage of this demographic. SOPA has business operations in Vietnam with a population of 100M, and about 55% are under 30. With a highly tech-savvy population, SE Asia embraces technology and digital solutions. The Company’s loyalty program can be interchangeable in other countries. Through SOPA’s business verticals in retail goods, fintech, telecom, travel, food/beverage, and digital marketing, Rokas gives an example where travel rewards in one country are available to purchase retail products in a different country. SOPA has business operations in Singapore, Vietnam, Philippines, Indonesia, and Thailand and is looking into expanding into Malaysia. 70% of the SE Asian population does not have a conventional banking account; they use digital wallets for purchases. Rokas believes SOPA has opportunities to expand its digital ecosystem to the “Unbanked.” The Company continues executing its business plan and wants to increase its digital ecosystem loyalty program. The loyalty app is available for iOS and Android downloads. The on-screen QR code is available during the show; download or visit Society Pass Incorporated – https://thesocietypass.com/.

PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) (“PreveCeutical”) Chairman and CEO Stephen Van Deventer talks with New to The Street’s TV Host Jane King. PreveCeutical is a medical science company that develops innovative options for preventive and curative therapies using natural and organic compounds. The Company can synthesize molecular organic compounds through its proprietary technology and extensive peptide library to create preventative medical solutions. Using the technology, PreveCeutical developed a compound tested on mice, providing pre-clinical results on a non-addictive pain treatment more potent than opioids and morphine with no significant side effects. A pharmaceutical journal published a peer-review of the pre-clinical results. Stephen has a background in investment banking and was involved in the cannabis industry. He was involved with Aurora Cannabis Company and is passionate about finding organic and natural medical preventative solutions. The scientific team at PreveCeutical consists of doctors, PhDs, and engineers, all with impressive credentials in the pharmacology and pharmaceutical industries. With pre-clinical solid data, the team is moving forward on a clinical trial with the hopes of obtaining fast-track regulatory approvals in the US, Europe, and Australia for commercial distribution of a novel non-addictive pain management drug. The on-screen QR code is available during the show; download or visit PreveCeutical Medical, Inc. – https://www.preveceutical.com/.

New to The Street’s TV Host Jane King, from the Nasdaq MarketSite studio, interviews Hope Tain, Artist/Owner of Hope Tain Oil Painting. Hope was born and raised in Beijing, China, and in the late 1990s she moved to the US to pursue her graduate degree in New York State. In 2011, Hope painted a portrait for her son as his birthday gift; she realized her talent and pursued her art career. As self-taught and working with oil, Tain creates beautiful art depicting portraits, landscapes, seascapes, and still life, anything that inspires her. Tain explains that she visualizes each oil canvas painting before beginning each artwork. Inspirations can come from the Master artists or the simplest of events in her life, but LOVE provides her with the most inspiration for her creativity. Art taught Hope anything is possible, and pursuing her passion becomes a fulfilling career. She is grateful for her family, friends, other artists, and the art gallery communities, all providing support and influential inspiration for her oils. Currently living in Massachusetts, artwork done by Hope Tain is available for sale, or you can commission her talent for your unique and personal piece of art. The on-screen QR code is available during the show; download or visit Hope Tain Oil Painting – https://www.hopetianart.com/.

This week’s New to the Street TV “Weekly Sekur Privacy & Sekur Security Segment” with internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO of Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) and TV Host / Multi-media Journalist Ana Berry discuss the most recent “Phishing” attack. Ana recently received a suspicious text message disguised as genuine from the United States Postal Service (USPS). Phishing is occurring on text messaging platforms, with the hacker’s objective for one to click the message link so malware downloads on the device. Alain states that Phishing increased rapidly during and after COVID because of the increased demand for online purchasers. During checkout, most sites ask for a phone number; the hackers have that information and now try to entice the unaware to click links on text messages. Sekur’s cybersecurity products never ask for a phone number. SekurVPN, SekurMail, and SekurMessenger, each with unique features, can significantly minimize the threat of becoming a cybersecurity victim. The SekurMessenger comes with the “Chat-by-Invite” feature, which allows for a close-loop, encrypted platform protecting the subscriber and chat recipient from a possible hack. The whole text message is within Sekur’s servers located in Switzerland. The “Chat-by-Invite” is available for use in 80 countries. SekurMail, with its SekurSend/SekurReply feature, offers subscribers another excellent option for secure encrypted communications. Alain believes that to enhance your internet invisibility and greatly diminish your web footprint, use the Company’s SekurVPN service; subscribers get a Swiss IP address. The Company is offering PROMO CODE: PRIVACY; subscribers can get an additional 15% off monthly and yearly subscriptions for five years. Sekur Private Data, Ltd. does no data mining, no internet traffic tracking, no shared servers, no open-platform coding, and no third-party providers, and never asks for a phone number, and the Company owns and operates its servers in Switzerland, a country with strict privacy laws. The on-screen QR code is available during the shows to download more info or visit Sekur Private Data, Ltd. – https://sekurprivatedata.com/, http://www.Sekur.com and https://www.sekurvpn.com/. “What is your privacy worth?”

About American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB):

American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB) operates primarily as a designer, manufacturer, and marketer of branded safes and personal security and self-defense products. The Company also designs and produces branded apparel and accessories – www.americanrebel.com & www.americanrebel.com/investor-relations.

About Society Pass Incorporated (NASDAQ: SOPA) ($SOPA):

Founded in 2018 as a data-driven loyalty, fintech, and e-commerce ecosystem in the fast-growing markets of Vietnam, Indonesia, Philippines, Singapore, and Thailand, which account for more than 80% of the Southeast Asia (SEA) population, and with offices located in Los Angeles, Bangkok, Ho Chi Minh City, Jakarta, Manila, and Singapore, Society Pass Incorporated (NASDAQ: SOPA) is an acquisition-focused holding company operating six interconnected verticals (loyalty, digital media, travel, telecoms, lifestyle, and F&B), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA. Society Pass leverages technology to tailor a more personalized experience for customers in the purchase journey and transform the entire SEA retail value chain. SOPA operates Thoughtful Media Group, a Thailand-based, social commerce-focused, premium digital video multi-platform network; NusaTrip, a leading Indonesia-based Online Travel Agency; Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator; Leflair.com, Vietnam’s leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in the Philippines; Handycart.vn, a leading online restaurant delivery service based in Vietnam; and Mangan.ph, a leading local restaurant delivery service in Philippines – https://thesocietypass.com/.

About PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF):

PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products. The Company aims to be a leader in the preventive health sciences sector. With the completion of three of its research programs, the Company is actively working on the development, clinical trials, and commercialization of its products and has filed several provisional patent applications to protect the intellectual property from its research programs – https://www.preveceutical.com/.

About Hope Tain Oil Painting:

Hope Tain Oil Painting’s Artist/Owner, Hope Tian, finds great excitement and creativity in exploring varied subjects and eclectic oil painting styles.  Her artwork ranges from impressionistic or post-impressionistic to expressionistic or fauvist to truly representational to abstract.  Hope’s paintings are heavily influenced by her keen interest in and ongoing study of master painters. Standing before Hope Tian’s original oil painting, there is a deep emotional expression, creatively textured layering, vividly vibrant colors, and lively free brush strokes ranging from the lightest touch to heavy, thick paint, all resulting in a unique artistic experience – https://www.hopetianart.com/.

About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF):

Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted emails, and secure communication tools. It sells its products through its websites, www.sekur.com, approved distributors, and telecommunication companies worldwide. Sekur Private Data, Ltd. serves consumers, businesses, and governments worldwide – https://www.sekurprivatedata.com and https://www.sekur.com; Twitter: @sekurprivate.

About New to The Street:

New to The Street is an FMW Media production that operates one of the longest-running US and International sponsored and syndicated Nielsen-rated programming television brands, “New to The Street. Since 2009, New to The Street has run biographical interview segment shows across major U.S. television networks. The Nielsen Rated and sponsored broadcasts programming platform reaches millions of homes in the US and international markets. FMW’s New to The Street / Newsmax televised broadcasting platform airs its syndication on Saturdays at 3:30 – 4:00 PM ET. The show also appears on Bloomberg and the FOX Business Network as sponsored programming. FMW is also one of the nation’s largest buyers of linear television, long and short-form paid programming – https://www.newsmaxtv.com/Shows/New-to-the-Street, https://www.newtothestreet.com/ & https://www.youtube.com/watch?v=4-G2–mRQUw&t=14s.

Forward-Looking Statements Disclaimer US/Canada:

This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements do not guarantee future performance or results and will not necessarily be accurate indications of when such performance or results are achieved. This press release should be considered in all filings of the Companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. These statements reflect management’s current beliefs and are based on information currently available to management as of the date hereof. Forward-looking information in this press release includes, without limiting the foregoing, expectations regarding agents that join Real. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

FMW Media Contact:
Monica Brennan
monica@NewtoTheStreet.com
1-917-330-2564

“New to The Street” Business Development Office
1-516-696-5900
Support@NewToTheStreet.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a4b7c17b-6423-479b-a6df-538a9d6f9969

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7d40201e-691f-48b2-9547-21f579bda0bb

Continue Reading

Cannabis

CBD Skin Care Market Size is projected to reach USD 6466.43 million by 2030, growing at a CAGR of 32.15%: Straits Research

Published

4 days ago

on

September 20, 2023

By

New York, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD), derived from cannabis resin, is non-intoxicating. Cannabinoid (CBD) is most typically used with oils. CBD oil has anti-inflammatory, antioxidant, and skin-soothing properties. CBD oil is currently a popular ingredient in skin care and personal care products.

Since marijuana and cannabis-based cosmetics were legalized, CBD-infused skin care products have gained popularity. CBD-infused skin care products are popular because they relax. Anti-inflammatory and anti-oxidant properties make it a promising skin care ingredient. CBD-based skincare products can improve sleep and treat eczema, psoriasis, and acne. CBD-based skin care is popular among cosmetic brands. CBD-infused skin care is marketed as “natural cosmetics” CBD skin care products are expected to become popularity due to their versatility.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: DRIVERS

  • Cannabis-Derived Skin Care Products Are Gaining Popularity

A surge in the working population around the world has increased spending power and awareness of the range of commodities on the market, boosting sales of quality products. These factors have led to growing global demand for natural and organic personal care items.

People are becoming increasingly familiar with the benefits of CBD skin care products, such as CBD oil in their daily coffee, using it to their skin to relieve pain, consuming it to relieve anxiety, and using it in their sex life.

  • Social-Media’s Impact on Skin Diseases

Because of pollution and UV radiation, which can cause skin burns, blackening, and cancer, consumers are turning to CBD-infused cosmetics and skincare products. Consumers’ increased acquaintance with the newest skin care products helps boost sales. Companies increasingly use celebrities to sell their products and spend a lot on advertising.

YouTube and Instagram are important influences on today’s society. These portals help people find CBD skin care products. Rising customer awareness of the benefits and availability of new products should benefit the global market in the futur

Global CBD Skin Care Market: KEY FUTURE OPPORTUNITIES

  • Technological Advances and Mergers Create New Opportunities

Recent scientific advances have resulted to innovative CBD extracts and combinations for skin care. CBD-infused goods from multinational firms are capturing new markets and establishing new cash streams. Avon plans to develop vegan skin care products with CBD oil in 2020. As the cannabis beauty industry grows, component approaches vary. These factors boost market growth.

A growing number of technological innovations are driven by a desire to lower production costs and to foster sustainable growth from 2022 to 2030.

Report Scope

Report Metric Details
Market Size by 2030 USD 6466.43 million
Market Size in 2021 USD 526.09 million
CAGR 32.15% (2022-2030)
Historical Data 2020-2021
Base Year 2022
Forecast Period 2023-2031
Forecast Units Value (USD million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology, By Application, By Location
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Kiehl’s LLC, Medical Marijuana, ENDOCA, Elixinol Global ltd, Lord Jones, Icanic Brands Company, Inc., LEEF Organics, The CBD Skincare Co, Kana Skincare, Apothecana, Josie Maran Cosmetics, FOLIUM BIOSCIENCES, CBD for life, Pacific Roots LLC,
Key Market Opportunities Technological Advances and Mergers Create New Opportunities
Key Market Drivers Cannabis-Derived Skin Care Products Are Gaining Popularity

Buy Now Full Report @ https://straitsresearch.com/buy-now/cbd-skin-care-market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CBD Skin Care Market.

North America, which had over 45% of the market in 2021, is expected to grow quickest. Demand for CBD skin care products in North America is expected to continue high due to a large client base and the legalization of marijuana. Due to legalization in 33 states and DC, the US possesses the world’s largest cannabis market. Cannabis legalization and well-known beauty product makers should boost industry growth in the next years.

CBD-infused skin care products may fuel US customer demand. The FDA Regulation of Cannabidiol (CBD) Products prohibits marijuana but not hemp or cannabis. Manufacturing and selling CBD derivatives is lawful. CBD derivatives may be used as lotions, serums, and ointments.

Asia Pacific will grow rapidly in the future years. China, India, Japan, and Korea are expected to see substantial growth. J-beauty and K-beauty lead the worldwide skincare market, despite cannabis being illegal in Asia. This market is expected to grow rapidly in Asia.

China is one of the main manufacturers of cannabis made from hemp, and the World Bank and IMF expect it to monopolize the market throughout the predicted period. China allows the production and sale of CBD products with a maximum 0.3% THC content from cannabis Sativa fruit, seed oil, and leaf extract. This benefits its use in high-end skincare and luxury cosmetics.

Due to changing legislation, India’s CBD skin care market is growing. The Narcotic Drugs and Psychotropic Substances Act of 1985 says it’s unlawful to produce cannabis in the U.S., although states can allow its commercial or research cultivation.

Key Highlights

  • The Global CBD Skin Care Market size is predicted to reach at USD 6466.43 million by 2030, increasing at a CAGR of 32.15% from 2022 to 2030.
  • By Source,the Global CBD Skin Care Market is segmented into Hemp and Marijuana. CBD skin care products derived from hemp maintained the biggest market share.
  • By Type,the Global CBD Skin Care Market is segmented into Oils, Creams & Moisturizers, Masks & Serums, Cleansers, and Others. In 2021, the market was led by skin care oils containing CBD.
  • By Region,the Global CBD Skin Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market share is dominated by North America.

Major Players in Global CBD Skin Care Market

  1. Kiehl’s LLC
  2. Medical Marijuana
  3. ENDOCA
  4. Elixinol Global ltd
  5. Lord Jones
  6. Icanic Brands Company, Inc.
  7. LEEF Organics
  8. The CBD Skincare Co
  9. Kana Skincare
  10. Apothecana
  11. Josie Maran Cosmetics
  12. FOLIUM BIOSCIENCES
  13. CBD for life
  14. Pacific Roots LLC
  15. Ecogen labs

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: Segmentation

BY SOURCE

  • Hemp
  • Marijuana

BY TYPE

  • Oils
  • Creams & Moisturizers
  • Masks & Serums
  • Cleansers
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa (MEA)

TABLE OF CONTENT

  1. EXECUTIVE SUMMARY
  2. RESEARCH SCOPE & SEGMENTATION
    1. Research Objectives
    2. Market Definition
    3. Limitations & Assumptions
    4. Market Scope & Segmentation
    5. Currency & Pricing Considered
  3. MARKET OPPORTUNITY ASSESSMENT
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    4. Investment Landscape
    5. New Business Models / Revenue Streams
    6. TAM
  1. MARKET TRENDS
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Human Factors
    6. Technology Factors
  1. MARKET ASSESSMENT
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Sales And Distribution Channel Analysis
    4. Average Pricing Analysis
    5. Patent Analysis
    6. M & A Agreements & Collabration Analysis
    7. Export Import Analysis
  1. ESG TRENDS
  2. GLOBAL CBD SKIN CARE MARKET SIZE ANALYSIS
    1. Global CBD Skin Care Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
  1. NORTH AMERICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Canada
  1. EUROPE MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Germany
    2. France
    3. Spain
    4. Italy
    5. Russia
    6. Nordic
    7. Benelux
    8. Rest Of Europe
  1. APAC MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Korea
    2. Japan
    3. India
    4. Australia
    5. Taiwan
    6. South East Asia
    7. Rest Of Asia-Pacific
  1. MIDDLE EAST AND AFRICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Turkey
    2. Saudi Arabia
    3. South Africa
    4. Egypt
    5. Nigeria
    6. Rest Of MEA
  1. LATAM MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Mexico
    2. Argentina
    3. Chile
    4. Colombia
    5. Rest Of LATAM
  1. COMPETITIVE ASSESSMENT
    1. CBD Skin Care Market Share By Manufacturers
    2. CBD Skin Care Market Ranking By Revenue For Manufacturers
    3. Competitive Dashboard
    4. Product Mapping
  1. MARKET PLAYERS ASSESSMENT
    1. Kiehl’s LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. Gross Margin
      6. Swot Analysis
      7. Recent Developmments
    1. Medical Marijuana
    2. ENDOCA
    3. Elixinol Global Ltd
    4. Lord Jones
    5. Icanic Brands Company, Inc.
    6. LEEF Organics
    7. The CBD Skincare Co
    8. Kana Skincare
    9. Apothecana
    10. Josie Maran Cosmetics
    11. FOLIUM BIOSCIENCES
    12. CBD For Life
    13. Pacific Roots LLC
    14. Ecogen Labs
  1. RESEARCH METHODOLOGY
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data From Secondary Sources
      1. Primary Data
        1. Key Data From Primary Sources
        2. Breakdown Of Primaries
      1. Secondary And Primary Research
        1. Key Industry Insights
    1. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    1. Research Assumptions
      1. Assumptions
    1. Limitations
    2. Risk Assessment
  1. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  1. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/cbd-skin-care-market/toc

News Media

Global CBD Skin Care Market Extends at a Healthy CAGR of 32.15%

Consumer Preference Drives the CBD Skin Care Products Market despite the Stringent Regulatory Landscape in Many Countries

Have a Look at the Related Research Report

Skincare Products Market: Information by Product Type (Facial Care, Lip Care, and Body Care), Category (Premium Skincare Products and Mass Skincare Products), and Region- Forecast till 2030

Skincare Body Products Market: Information by Gender (Male and Female), Product (Face Creams and Moisturizers), and Region — Forecast till 2030

Organic Skin Care Market: Information by Product (Face Cleanser, Face Serum), Distribution Channel (Online, Supermarket/Hypermarket), and Region — Forecast till 2030

Facial Skincare Products Market: Information by Product Type (Facial Cleanser, Toner, Facial Serum, Eye Creams), Distribution Channel (Specialty Stores), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (the U.S.)

+91 8087085354 (APAC)

+44 203 695 0070 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Continue Reading

Cannabis

Legal Cannabis Commercialization Bolsters Vacuum Oven Demand; Essential Role in Processing Extracts and Enhancing Safety Recognized

Published

4 days ago

on

September 20, 2023

By

Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, with expectations to reach US$ 343.2 million by 2028. This growth reflects a robust compound annual growth rate (CAGR) of 6.38% during the forecast period from 2023 to 2028.

Vacuum ovens, highly versatile equipment with applications in laboratory research, engineering, and industry, play a pivotal role in the heat treatment process. These ovens conduct heat treatment within an airtight vessel, allowing the creation of a vacuum within the chamber. This capability enables precise control over the heat treatment process and offers several advantages, including:

  1. Prevention of surface reactions like oxidation or decarburization.
  2. Removal of surface contaminants such as oxide films and residual traces of lubricants.
  3. Introduction of substances to the surface layers of the work.
  4. Removal of dissolved contaminating materials from metals through degassing.

The vacuum oven market’s growth is closely tied to the legalization of cannabis in many parts of the world and the subsequent commercialization of related products. Vacuum ovens play a crucial role for legal cannabis growers in processing cannabis extract BHOs (Butane Hash oil).

These ovens enable the production of purified oil extracts while reducing the risk of fires during the extraction process. Furthermore, vacuum ovens are used in the medical industry to eliminate potentially toxic chemicals from medical devices, including artificial heart valves, pacemakers, and joint implants. These ovens also find application in testing how devices respond to the high vacuum environment of space, making them valuable equipment for the aerospace industry.

Key Market Segmentation:

The global vacuum ovens market report by [Publisher Name] analyzes key trends within each sub-segment and provides forecasts at the global and regional levels for the period from 2023 to 2028. The market is segmented based on product type and application.

Product Type:

  • < 200
  • 200-300
  • > 300

Application:

  • Home Appliances
  • Commercial Appliances

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report offers a comprehensive analysis of the competitive landscape, featuring key players such as Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella, and Yamato Scientific.

This report provides in-depth insights into the global vacuum ovens market, covering macro overviews, micro details of industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, and more. It is a crucial resource for entrepreneurs, investors, researchers, consultants, business strategists, and anyone involved or planning to enter the vacuum ovens industry.

Key Questions Answered in This Report:

  • How has the global vacuum ovens market performed and what are the growth prospects in the coming years?
  • Which regions are the primary markets in the global vacuum ovens industry?
  • What impact has COVID-19 had on the global vacuum ovens industry?
  • How is the global vacuum ovens market segmented based on product type?
  • What are the applications driving the global vacuum ovens market?
  • What are the price trends for vacuum ovens?
  • What is the value chain structure of the global vacuum ovens market?
  • What are the key factors driving growth and challenges in the global vacuum ovens market?
  • Who are the major players in the global vacuum ovens market, and what is the competitive landscape like?
  • How are vacuum ovens manufactured?

Key Attributes:

Report Attribute Details
No. of Pages 139
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $254.3 Million
Forecasted Market Value (USD) by 2028 $343.2 Million
Compound Annual Growth Rate 5.1%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/n83xum

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment 



 


													

													

														Continue Reading
													

												

											

										

																	

							

													

						

													

						
			

				Advertisement
				
			

		

		

		
Latest news

		

		
			
											

				

							

					

						Trending on Grassnews
					

					
				

						

		

		

			

			

				
				

					

						

							
GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..


Contact us: sales@hipther.agency


Editorial / PR Submissions


Copyright © 2007 - 2023 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania